Digital Programs for Cancer

(EMBRACE Trial)

This trial tests how digital programs can assist individuals recently diagnosed with cancer. The goal is to determine if these programs can enhance patients' health, wellbeing, and daily functioning. Participants will join one of two groups, each engaging in different digital courses and activities, including the Digital Information Series for Cancer and MINDSET. Ideal candidates for this trial have a recent initial diagnosis of non-metastatic cancer, are currently undergoing or planning to undergo systemic treatment, and have access to a digital device like a smartphone or tablet. As an unphased trial, this study provides a unique opportunity to explore innovative digital support tools that could enhance the cancer care experience.

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current treatments, as the trial focuses on digital programs for cancer patients.

Research has shown that the digital MINDSET program is safe for cancer patients. In previous studies, this 2.5-hour online course improved patients' overall health, including physical, social, and emotional well-being. No major side effects were reported, indicating it is well-tolerated.

The Digital Information Series for Cancer helps patients manage their treatment. It offers educational content, focusing on guidance and support rather than medical procedures, making it generally safe.

Researchers are excited about the "Digital Programs for Cancer" trial because it introduces innovative, digital approaches to support cancer patients beyond standard treatments like chemotherapy, radiation, and surgery. The MINDSET program is unique because it offers a 2.5-hour mobile health (mHealth) intervention that combines films and interactive reflection activities. These components are designed to improve the physical, social, emotional, and functional quality of life for patients by focusing on changing maladaptive mindsets. Additionally, the Digital Information Series for Cancer provides educational content in a hybrid format, helping patients develop coping strategies through engaging videos and questions. These digital interventions are pioneering because they aim to enhance the overall well-being of patients undergoing systemic cancer treatment by addressing the psychological aspects of their journey.

This trial compares two digital programs for cancer patients. Studies have shown that digital programs like MINDSET, one of the programs in this trial, can significantly improve cancer patients' health. Research indicates that these programs enhance physical, social, and emotional well-being. Patients have reported better mental health, with reduced anxiety and depression, and an improved quality of life. The MINDSET program includes films and reflection exercises that help change negative thoughts and encourage positive thinking. Meanwhile, the Digital Information Series for Cancer, another program in this trial, provides educational content on coping strategies, supporting patients during treatment. Both programs aim to enhance cancer patients' health and well-being through personalized digital experiences.¹²⁴⁶⁷